1.
Salud pública Méx
;
59(2): 120-122, mar.-abr. 2017. tab
Artículo
en Español
| LILACS
| ID: biblio-846070
2.
Indian J Pediatr
;
2008 Jul; 75(7): 739-43
Artículo
en Inglés
| IMSEAR
| ID: sea-83179
RESUMEN
The management of Beta Thalassemia, the commonest form of hemolytic anemia in children, has changed significantly in the last few years. With the availability of better transfusion regimen, iron chelation therapy, proper management of complications and good supportive care, it is now possible for a thalassemic child to have a near normal life span with a good quality of life.